Advertisement
Canada markets close in 41 minutes
  • S&P/TSX

    22,210.29
    +103.21 (+0.47%)
     
  • S&P 500

    5,261.40
    +12.91 (+0.25%)
     
  • DOW

    39,826.40
    +66.32 (+0.17%)
     
  • CAD/USD

    0.7382
    +0.0010 (+0.14%)
     
  • CRUDE OIL

    83.09
    +1.74 (+2.14%)
     
  • Bitcoin CAD

    95,875.00
    +2,679.73 (+2.88%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,241.90
    +29.20 (+1.32%)
     
  • RUSSELL 2000

    2,124.61
    +10.26 (+0.49%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • NASDAQ

    16,403.85
    +4.33 (+0.03%)
     
  • VOLATILITY

    12.91
    +0.13 (+1.02%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • CAD/EUR

    0.6842
    +0.0037 (+0.54%)
     

RDInvesting Provides Investors with Free In-Depth Equity Reports on CROX, DE, DXCM and NTRI

Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous s stock reports and market updates.

Crocs, Inc. (NASDAQ:CROX - News) shares increased 2.03 percent to close at $15.09 a share Thursday. The stock traded between $14.74 and $15.11 on volume of 1.64 million shares traded. Analysts at Buckingham Research Group have recently initiated coverage on the company with a "buy" rating and a price target of $20.00. Shares of Crocs have fallen approximately 5.0 percent year-to-date.

Find out more about Crocs including full access to the free equity report at:
www.RDInvesting.com/CROX

Deere & Company (NYSE:DE - News) shares declined 0.69 percent to close at $92.74 a share Thursday. The stock traded between $92.54 and $94.58 on volume of 4.37 million shares traded. Analysts at Imperial Capital have recently upgraded the company’s rating to "neutral" from "cautious". Shares of Deere & Company have gained approximately 1.50 percent year-to-date.

ADVERTISEMENT

Find out more about Deere & Company including full access to the free equity report at:
www.RDInvesting.com/DE

DexCom, Inc. (NASDAQ:DXCM - News) shares dropped 5.83 percent to close at $36.05 a share Thursday. The stock traded between $36.02 and $39.48 on volume of 1.46 million shares traded. Analysts at Sterne Agee have recently upgraded the company’s rating to "buy" from "neutral". Shares of DexCom have gained approximately 2.0 percent year-to-date.

Find out more about DexCom including full access to the free equity report at:
www.RDInvesting.com/DXCM

NutriSystem Inc. (NASDAQ:NTRI - News) shares declined 1.40 percent to close at $14.80 a share Thursday. The stock traded between $14.76 and $15.45 on volume of 646,641 shares traded. Analysts at B. Riley & Co. have recently initiated coverage on the company with a "buy" rating and a price target of $20.00. Shares of NutriSystem have fallen approximately 10.0 percent year-to-date.

Find out more about NutriSystem including full access to the free equity report at:
www.RDInvesting.com/NTRI

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.

Contact:
Research Driven Investing
info@rdinvesting.com